Literature DB >> 16888292

Further lessons from the TGN1412 tragedy.

Michael D E Goodyear.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16888292      PMCID： PMC1526936          DOI： 10.1136/bmj.38929.647662.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Human error: models and management.

Authors:  J Reason
Journal:  BMJ       Date:  2000-03-18

2.  Guiding Principles for Pharmaceutical Physicians from the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK.

Authors:  R Bickerstaffe; P Brock; J-M Husson; I Rubin; K Bragman; K Paterson; A Sommerville
Journal:  Int J Clin Pract       Date:  2006-02       Impact factor: 2.503

3.  Clinical trial registration: transparency is the watchword.

Authors:  Ida Sim; An-Wen Chan; A Metin Gülmezoglu; Tim Evans; Tikki Pang
Journal:  Lancet       Date:  2006-05-20       Impact factor: 79.321

4.  Learning from the TGN1412 trial.

Authors:  Michael Goodyear
Journal:  BMJ       Date:  2006-03-22

5.  Ethics and pharmaceutical medicine -- the full report of the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK.

Authors:  R Bickerstaffe; P Brock; J-M Husson; I Rubin; K Bragman; K Paterson; A Sommerville
Journal:  Int J Clin Pract       Date:  2006-02       Impact factor: 2.503
  5 in total
  5 in total

1.  A model clinical trials agreement.

Authors:  Michael D E Goodyear
Journal:  BMJ       Date:  2006-11-17

Review 2.  Surgical research in the UK.

Authors:  Thomas Edward Woodcock
Journal:  Ann R Coll Surg Engl       Date:  2009-04       Impact factor: 1.891

Review 3.  [Drug trials in humans. Risks in the light of the London catastrophe].

Authors:  A Otte
Journal:  Internist (Berl)       Date:  2007-06       Impact factor: 0.743

4.  TGN1412: From Discovery to Disaster.

Authors:  H Attarwala
Journal:  J Young Pharm       Date:  2010-07

5.  Inadequate dissemination of phase I trials: a retrospective cohort study.

Authors:  Evelyne Decullier; An-Wen Chan; François Chapuis
Journal:  PLoS Med       Date:  2009-02-17       Impact factor: 11.069
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.